000739:SHE
Apeloa Pharmaceutical Co Ltd
CN¥23,42
arrow_downward
-1,64%(-0,39) 1D
16 Okt., 15:04:48 GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 000739...
Open
CN¥24,04
High
CN¥24,76
Low
CN¥23,09
Mkt. cap
28,68 mjd
Avg. vol.
16,27 m
Volume
15,09 m
Dividend
1,61%
Quarterly dividend
CN¥0,09
Ex-dividend date
08 Okt. 2026
P/E ratio
31,78
52-wk high
CN¥28,50
52-wk low
CN¥14,89
EPS
CN¥0,74
Shares outstanding
1,16 mjd
No. of employees
7 k
Open
CN¥24,04
High
CN¥24,76
Low
CN¥23,09
Mkt. cap
28,68 mjd
Avg. vol.
16,27 m
Volume
15,09 m
Dividend
1,61%
Quarterly dividend
CN¥0,09
Ex-dividend date
08 Okt. 2026
P/E ratio
31,78
52-wk high
CN¥28,50
52-wk low
CN¥14,89
EPS
CN¥0,74
Shares outstanding
1,16 mjd
No. of employees
7 k
News stories
From web sources and news partners
Investor's Business Daily
·
1 uur gelede
Stock Market Ends Week With Software Sell-Off; Nasdaq Dives 2%, Gives Up 200-Day Line
MarketBeat
·
5 minute gelede
CRISPR Therapeutics (NASDAQ:CRSP) Director Sells 14,514 Shares of Stock
Investing News Network
·
20 minute gelede
Kopin to Host Live YouTube "Ask Me Anything" Panel from Nasdaq MarketSite on the Future of AI Infrastructure
Profile
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
About Apeloa Pharmaceutical Co Ltd